📰 Quest Diagnostics News
Page 100 - Quest Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Quest Diagnostics. Real-time updates on events, politics, business and more.
August 4, 2023
Operator: Good day, and thank you for standing by. Welcome to the OraSure Technologies 2023 Second Quarter Earnings Conference Call. At this time all participants are in a listen-only mode.
August 4, 2023
Hoylecohen LLC lowered its position in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 0.3% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 31,795 shares of the medical research company’s stock after selling 80 shares during the quarter. Hoylecohen LLC’s […]
August 3, 2023
Clinical lab giant Quest Diagnostics has launched the first direct-to-consumer blood test that can help identify potential risks associated with Alzheimer's disease.
August 3, 2023
Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "Global Colorectal Cancer (CRC) Screening Market (2023 Edition): Analysis by Screening Type, End-Use, By...
August 3, 2023
Global Cloud Database and DBaaS Market Global Cloud Database and DBaaS Market Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "Global Colorectal Cancer (CRC) Screening Market (2023 Edition): Analysis by Screening Type, End-Use, By Region, By Country: Market Insights and Forecast (2019-2029)" report has been added to ResearchAndMarkets.com's offering. The Global Colorectal Cancer (CRC) Screening Market is expected to generate USD 27.7 billion by the end of 2029, up from USD 17.2 bill...
August 3, 2023
/PRNewswire/ -- The genetic testing market is estimated to grow at a CAGR of 12.78% between 2022 and 2027. The market size is forecast to increase by USD 7,103....
August 3, 2023
What’s the primary goal of workplace drug testing? Why is it better for employers to anchor their workplace drug testing policy on deterrence?
August 3, 2023
Scissortail Wealth Management LLC purchased a new position in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) in the first quarter, according to its most recent filing with the SEC. The firm purchased 829 shares of the medical research company’s stock, valued at approximately $3,574,367,000. A number of other large investors have also recently […]
August 3, 2023
A blood-based biomarker test that assesses beta amyloid protein has been made available by Quest Diagnostics to help individuals identify their risk of developing Alzheimer disease.